Procentdelen af nogle bivirkninger var højere hos de 40 patienter, hvor dosis blev øget til 800 mg daglig sammenlignet med patientpopulationen inden dosisstigning (n=551).
The percentage of some adverse reactions was higher in the 40 patients in whom the dose was increased to 800 mg daily compared to the population of patients before dose increase (n=551).